Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZoneX is a brand of tobacco-free nicotine pouches designed for oral nicotine delivery. These compact pouches contain pharmaceutical-grade nicotine, plant fibers (such as wheat or bamboo), flavorings, humectants, and other food-grade ingredients. They are intended to be placed between the gum and lip, allowing nicotine to be absorbed through the oral mucosa. ZoneX serves as an alternative to traditional smoking, vaping, and conventional snus, aiming to provide a potentially harm-reduced method for consuming nicotine without tobacco combustion. The product is available in various nicotine strengths and is part of the Next Generation Products (NGP) category focused on tobacco harm reduction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZoneX.